An interventional study of Lidocaine patch and hypafix and hypafix in Gallbladder Diseases, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-12-19.
Sponsored by Ajou University School of Medicine · Not applicable, Interventional, and Prevention
The primary purpose of this study is to investigate the effect of lidocaine patch on the shoulder pain score after end of surgery.
The secondary purpose of this study is to investigate the effect of lidocaine patch on the total number of analgesic request on ward.
91 studies on the registry are indexed under Gallbladder Diseases; 19 are open to participants now.
This study's enrollment of 63 is below the median of 84 across 59 interventional studies indexed under Gallbladder Diseases.
Browse Gallbladder Diseases studies →Ajou University School of Medicine is the lead sponsor of 171 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Lidocaine patch and Hypafix
Drug: Lidocaine patch and hypafix
Just Hypafix
Drug: hypafix
Appliance of Lidocaine patch and hypafix on both shoulder tip after anesthetic induction
Appliance of hypafix on both shoulder tip after anesthetic induction
Shoulder pain score
Time frame: Change from baseline shoulder pain score up to 24 hr after end of surgery
Total number of analgesics request on ward
Time frame: Up to postoperative day 3
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ajou University School of Medicine